Syngene International Ltd

Syngene International Limited announced an investment of Rs 25.20 crore in Ampin C&I Power Twelve Private Limited to acquire a 12.44% stake, representing 25,20,000 equity shares at Rs 10 per share, with the allotment expected within 30 days. The acquisition, which does not constitute a related-party transaction, will enable Syngene to enhance renewable power consumption, reduce energy costs, and advance its decarbonization goals, aligning with the company’s renewable energy objectives.

Net loss of Syngene International reported to Rs 9.00 crore in the quarter ended June 2026 as against net profit of Rs 86.70 crore during the previous quarter ended June 2025. Sales declined 15.84% to Rs 736.00 crore in the quarter ended June 2026 as against Rs 874.50 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales736.00874.50 -16 OPM %12.3423.60 - PBDT106.50212.50 -50 PBT-5.70101.30 PL NP-9.0086.70 PL Powered by Capital Market - Live

Earnings before interest and taxes (EBIT) and profit before tax (PBT) generally increased between Q4 FY24 and Q3 FY26, though revenue growth appears to be slowing, according to recently released financial data. The company reported EBIT of 1,129 million INR in Q4 FY24, rising to 1,129 million INR in Q3 FY26. However, exceptional items significantly impacted profitability in several periods, including a 579 million INR negative impact in Q3 FY26 due to write-offs, the impact of new labor codes, and termination benefits. The acquisition of a biologics site in the USA in Q3 FY25 resulted in increased depreciation, and the company is navigating the complexities of new labor regulations, which initially resulted in a larger-than-anticipated impact. Further investigation is warranted into revenue drivers, acquisition integration, and the ongoing implications of the labor code changes.

Syngene International will hold a meeting of the Board of Directors of the Company on 29 July 2026.

He succeeds Peter Bains, who completed his tenure as MD & CEO on 30 June 2026. Siddharth Mittal joins Syngene from Biocon, where he most recently served as managing director and CEO. During his 13-year tenure at Biocon, he also served as chief financial officer (CFO) before taking over as MD & CEO. He played a key role in shaping the company's long-term strategy, strengthening commercial operations, expanding its global presence, securing key regulatory approvals, commercializing Biocon's GLP-1 portfolio across major international markets, and driving strategic partnerships and operational excellence. Syngene International is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The company's consolidated net profit declined 19.31% to Rs 147.90 crore on a 1.82% rise in revenue from operations to Rs 1,036.50 crore in Q4 FY26 over Q4 FY25. Shares of Syngene International fell 1.83% to close at Rs 431.55 on the BSE.Powered by Capital Market - Live

Cemindia Projects Ltd, Meesho Ltd, Newgen Software Technologies Ltd, Navin Fluorine International Ltd are among the other stocks to see a surge in volumes on NSE today, 30 April 2026.Syngene International Ltd notched up volume of 484.8 lakh shares by 14:14 IST on NSE, a 69.03 fold spurt over two-week average daily volume of 7.02 lakh shares. The stock rose 13.14% to Rs.488.95. Volumes stood at 6.31 lakh shares in the last session.Cemindia Projects Ltd notched up volume of 197.2 lakh shares by 14:14 IST on NSE, a 61.91 fold spurt over two-week average daily volume of 3.19 lakh shares. The stock rose 20.00% to Rs.815.25. Volumes stood at 5.3 lakh shares in the last session.Meesho Ltd saw volume of 1183.74 lakh shares by 14:14 IST on NSE, a 14.24 fold spurt over two-week average daily volume of 83.13 lakh shares. The stock increased 12.20% to Rs.193.75. Volumes stood at 43.37 lakh shares in the last session.Newgen Software Technologies Ltd witnessed volume of 105.24 lakh shares by 14:14 IST on NSE, a 9.22 times surge over two-week average daily volume of 11.42 lakh shares. The stock increased 6.71% to Rs.512.35. Volumes stood at 6.86 lakh shares in the last session.Navin Fluorine International Ltd clocked volume of 20.53 lakh shares by 14:14 IST on NSE, a 8.19 times surge over two-week average daily volume of 2.51 lakh shares. The stock gained 0.69% to Rs.6,805.00. Volumes stood at 3.15 lakh shares in the last session.Powered by Capital Market - Live

Syngene International announced that the Board of Directors of the Company at its meeting held on 29 April 2026, inter alia, have recommended the final dividend of Rs 1.25 per equity Share (i.e. 12.5%) , subject to the approval of the shareholders.

Syngene International announced that the 33th Annual General Meeting(AGM) of the company will be held on 29 July 2026.

Net profit of Syngene International declined 19.31% to Rs 147.90 crore in the quarter ended March 2026 as against Rs 183.30 crore during the previous quarter ended March 2025. Sales rose 1.82% to Rs 1036.50 crore in the quarter ended March 2026 as against Rs 1018.00 crore during the previous quarter ended March 2025. For the full year,net profit declined 36.17% to Rs 316.70 crore in the year ended March 2026 as against Rs 496.20 crore during the previous year ended March 2025. Sales rose 2.64% to Rs 3738.70 crore in the year ended March 2026 as against Rs 3642.40 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1036.501018.00 2 3738.703642.40 3 OPM %29.2733.75 -24.5728.60 - PBDT313.50346.60 -10 940.401060.50 -11 PBT202.00240.50 -16 487.50627.90 -22 NP147.90183.30 -19 316.70496.20 -36 Powered by Capital Market - Live

Syngene International will hold a meeting of the Board of Directors of the Company on 29 April 2026.